Dainippon Sumitomo (DS) Pharma Animal Health starts clinical trial on stem cell therapy for dogs

In the experimental design, mesenchymal stem cells are obtained from adipose tissue and applied to dogs who suffer from hernia. The company, a subsidiary of DS Pharma, cooperates with J-ARM Co., Osaka.

DS Pharma Animal Health news release, April 19, 2018

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny